Monash IVF has agreed to a $56 million settlement in a class action involving over 700 former patients whose embryos were mishandled during genetic screenings. Allegations included inaccurate tests leading to the loss of viable pregnancies, and fraudulent activities surrounding clinical trial documentation. This settlement, while confirming the mishap, does not come with any admission of liability from Monash IVF. The firm opted for a resolution through mediation to prioritize patient interests over a lengthy trial process.
The managing principal of Margalit Injury Lawyers, Michel Margalit, emphasized the significance of the settlement in bringing justice for her clients, stating that without the class action, Monash IVF’s issues would likely have remained concealed. Margalit pointed out that the wellbeing of patients should take precedence in IVF services, highlighting the ethical responsibilities of such providers, which include transparency and honesty in patient dealings.
Collection
[
|
...
]